Skip to content
drillr.ai
Sign up
ResearchJBTM

[JBTM] JBT Marel Thesis 2026: A Combined Food-Tech Equipment Leader With a Big Recurring Aftermarket and Merger Synergies

Ddrillr ResearchOriginal research
Published 30 min read

JBT Marel Corporation (NYSE: JBTM) is a global food & beverage processing equipment and automation company headquartered in Chicago, formed in ~2025 when JBT Corporation (spun off from FMC Technologies in 2008, and which spun off its AeroTech airport-equipment business to Oshkosh in ~2023 to become a pure-play food-tech company) acquired Marel hf. of Iceland, creating JBT Marel. JBTM enters FY2026 with FY2025 revenue ~$3.5-4.5B (boosted by the Marel consolidation, then ~flat-to-modest organically — JBT standalone was ~$1.7-1.8B pre-merger) and adj. EPS ~$3.50-5.50 (highly merger-integration- and food-capex-cycle-sensitive; GAAP lumpy on acquisition/integration charges and amortization), reflecting JBT FoodTech revenue plus Marel revenue plus recurring aftermarket/parts/service/software revenue (~50%+ of total), all under President + CEO Brian Deck (~5-7 year tenure as JBT/JBT Marel CEO since ~2019, prior JBT CFO/finance background, architect of the JBT FoodTech focus (post the AeroTech spin), the Marel acquisition, the integration-synergy + deleveraging program, and the recurring-revenue + secular-automation strategy). The first thesis pillar is the Food-Processing-Equipment Platform (JBT FoodTech + Marel Protein/Poultry/Fish) + the Recurring Aftermarket/Service/Software Base + the New-Equipment Cycle pipeline: JBT FoodTech — food processing + packaging equipment across protein (cooking, freezing/chilling, portioning, coating, frying — meat, poultry, seafood), liquid foods (filling, closing, sterilization/aseptic, pasteurization — juices, dairy, sauces, soups, RTD), fruit & vegetable processing, bakery, ready meals, pet food and plant-based; Marel — protein-processing equipment (poultry, meat, fish) — primary (slaughter, cutting, deboning), secondary (portioning, marinating, coating, cooking, freezing) and further (forming, breading, frying) processing — plus Innova (Marel's food-production software — yield management, traceability, line control); together = the #1 / top-tier global player in food-processing equipment (a fragmented market — JBT + Marel + GEA + Bühler + Krones + Middleby's food-processing segment + many smaller players — the combination gives scale, breadth across categories/processing steps/geographies, and a leading position in protein especially); customers are large food/beverage manufacturers and protein processors (Tyson, JBS, Cargill, Marfrig, etc.) plus dairy/beverage companies plus foodservice plus co-packers, globally; the recurring-revenue base is ~50%+ of revenue (aftermarket parts — the installed base generates ongoing replacement-part demand — plus service — maintenance, repair, technical support, line optimization — plus software — Innova + JBT's digital, subscription/SaaS-like), the quality piece (higher-margin, less-cyclical, sticky, growing with the installed base) while new-equipment orders are the cyclical piece; the new-equipment cycle (food/beverage processors' capital spending — tied to volumes, capacity needs, automation investments, food-safety upgrades, new-product launches) was soft in 2023-2025 (cautious food-manufacturer capex — inflation, demand normalization, high rates), with the recovery thesis being food-manufacturer capex picking up → new-equipment orders + revenue + the backlog up; and the secular tailwinds — automation/labor-savings (a tight, expensive, high-turnover food-plant labor market → processors automate), food safety (regulation + brand-protection → equipment upgrades), protein demand (growing global protein consumption, especially poultry → more capacity), sustainability (energy/water efficiency, waste reduction), yield optimization (squeezing more product out of each input — JBT Marel's software + equipment); FY2026 catalyst is recurring revenue growing with the installed base + the combined-company scale + the Innova/digital push (the mix rising toward ~50%+ and higher), new-equipment orders recovering as food-manufacturer capex picks up (the backlog growing), the category/geographic mix (protein the biggest, riding the protein-demand tailwind), the secular tailwinds driving demand, and cross-selling (the combined portfolio — revenue synergies). The second pillar is the JBT-Marel Integration Synergies + Deleveraging + Capital + the Secular Automation/Protein Tailwinds pipeline: the JBT-Marel merger (~2025) — a cash-and-stock deal (JBT shareholders + former Marel shareholders both own the combined JBT Marel) — the rationale being scale, breadth, complementary portfolios (JBT strong in liquid foods and some protein; Marel strong in protein primary/secondary/further processing), cross-selling, a stronger software/digital offering (Innova + JBT's digital), and cost synergies; the cost synergies target meaningful annual savings (procurement — combined purchasing power — manufacturing footprint — consolidating/optimizing plants — SG&A — eliminating duplicate corporate/back-office — R&D efficiency, IT — one ERP/systems) on a multi-year ramp, plus revenue synergies (cross-selling — a more complete solution offering) — the synergy realization is a key part of the value-creation thesis; the integration risk/cost — merging two big companies (US JBT + Icelandic Marel — different countries, cultures, ERP systems, manufacturing networks) carries integration risk plus upfront integration costs (consultants, IT, restructuring — a multi-year spend depressing near-term GAAP earnings); the deleveraging — the Marel acquisition added debt (JBT took on debt + issued stock to fund the cash portion + assumed Marel's debt) → JBT Marel carries a moderately-heavy debt load post-merger — ~3-4x net leverage initially — the free cash flow + the synergies + EBITDA growth paying it down → deleveraging is a key part of the thesis (a deleveraging-driven value transfer to equity); the capital return is modest (a small dividend — JBT has paid one for years — plus buybacks — modest, with capital prioritized to deleveraging + integration + reinvestment near-term); and the recurring-revenue + software upside (as the combined installed base grows + the software offering scales, the recurring/software revenue mix rises → higher-quality, less-cyclical revenue → a multiple re-rating potential — the market values high-recurring-revenue equipment companies more richly); FY2026 catalyst is the synergy realization (the cost-synergy ramp continuing toward the multi-year target; revenue synergies starting), the integration progress (ERP/systems integration, manufacturing-footprint consolidation, organizational integration), deleveraging (net debt/EBITDA toward ~2-3x — free cash flow + synergies + EBITDA growth + lower interest expense to EPS), the recurring/software revenue mix rising, the new-equipment-cycle recovery, the dividend (maintained/grown) + modest buybacks (growing as the balance sheet heals), and the secular automation/protein/sustainability tailwinds. The capital story: a ~$0.40-0.44 aggregate annual dividend per share (~0.3-0.6% yield; quarterly ~$0.10; maintained through the merger), modest buybacks (~$0-0.3B annual — capital prioritized to deleveraging + integration + reinvestment near-term), ~$1.5-2.8B net debt (moderately heavy post-merger — the debt to fund the Marel deal + assumed Marel debt; a term loan + senior notes; the free cash flow + synergies + EBITDA growth paying it down), ~2.5-4.0x net debt/EBITDA (elevated initially — and the soft-EBITDA year makes it worse; deleveraging toward ~2-3x), a BB+/Ba1 to BBB-/Baa3 crossover credit profile (solid for an equipment company with a ~50%+ recurring-revenue base; deleveraging should support an IG profile over time), ~70-80M diluted shares (roughly stable post-merger — the merger added shares (the stock portion); modest buybacks), ~$0.4-0.8B liquidity and free cash flow that should grow as the synergies ramp and the new-equipment cycle recovers. At ~$80-140 per share on ~70-80M shares (~$6-11B equity, ~$8-14B EV) JBTM trades at ~15-25x P/E, ~9-14x EV/EBITDA and ~2-3x EV/Sales versus food-processing-equipment and process-equipment peers GEA Group, Krones, Middleby (its food-processing segment), Tetra Pak (private), Bühler (private), Roper Technologies (for the recurring-revenue-re-rating comp), Dover, Ingersoll Rand, Graco, Nordson and Lincoln Electric. FY2026 base case is ~$3.6-4.7B revenue + ~$3.50-5.50 adj. EPS + ~14-18%+ adj. EBITDA margin (rising on synergies) + ~2.5-4.0x → ~2-3x net debt/EBITDA (deleveraging) + the dividend and modest buybacks with the synergy ramp on track; bull case ~$3.9-5.0B revenue + ~$5.00-7.00 adj. EPS on a new-equipment-cycle recovery, the recurring revenue and secular tailwinds, cross-selling, the cost synergies fully realized, revenue synergies materializing, a smoothly completed integration, deleveraging toward ~2x with an IG-profile re-rating, the recurring/software revenue mix rising (a recurring-revenue-driven multiple re-rating toward a Roper-style process-equipment compounder), the dividend and growing buybacks, and a multiple re-rating; bear case ~$3.4-3.8B revenue + ~$2.80-3.80 adj. EPS on competitive pressure (GEA, Krones, Middleby, Tetra Pak, Bühler exploiting JBT Marel's integration distraction), a prolonged soft new-equipment cycle, integration-execution missteps, the deleveraging stalling, a protein-demand/agriculture-cycle shock (commodity-price pressure on processors, animal-disease outbreaks), customer-concentration pressure, a credit-rating concern, the integration-cost drag persisting, and a high-P/E-without-the-recurring-re-rating de-rating. The thesis depends on the Food-Processing-Equipment Platform pipeline plus the JBT-Marel Integration Synergies + Deleveraging + Capital pipeline plus the #1/top-tier global food-processing-equipment position plus the protein strength plus the ~50%+ recurring revenue (the quality, less-cyclical base) plus the JBT-Marel merger synergies (cost + revenue) plus the integration execution plus the deleveraging (net debt/EBITDA toward ~2-3x) plus the new-equipment-cycle recovery plus the secular automation/protein/sustainability tailwinds plus the recurring/software revenue mix rising plus the dividend plus modest buybacks and Brian Deck's integration-synergy, deleveraging and recurring-revenue execution.

[JBTM] JBT Marel Thesis 2026: A Combined Food-Tech Equipment Leader With a Big Recurring Aftermarket and Merger Synergies

Key Takeaways

  • JBTM FY2025 revenue ~$3.5-4.5B (boosted by the Marel consolidation, then ~flat-to-modest organically) with adj. EPS ~$3.50-5.50 (selected various aggregate ~~~~highly merger-integration- + food-capex-cycle-sensitive; GAAP lumpy on acquisition/integration charges + amortization; the thesis is synergy realization + a new-equipment-cycle recovery + deleveraging) reflecting continued ~~~JBT FoodTech (food processing + packaging equipment) revenue + ~~~Marel (protein/poultry/meat/fish processing + secondary/further processing + Innova software) revenue + ~~~recurring aftermarket/parts/service/software revenue (~50%+ of total) under continued President + CEO Brian Deck (~~~~~5-7 year tenure as JBT/JBT Marel CEO since ~~2019; selected primary post-2019 succession (as JBT CEO) + selected various aggregate ~~~~~~~~prior JBT CFO + finance background + selected primary architect of post-2019-2025 ~~the JBT FoodTech focus (after spinning off the AeroTech airport-equipment business in ~2023, JBT became a pure-play food-tech company) + the transformational Marel acquisition (~2025 — JBT acquired Marel hf. of Iceland, creating JBT Marel — the #1 / top-tier global food-processing-equipment company) + the integration-synergy + deleveraging program + the recurring-revenue + secular-automation strategy).
  • The Food-Processing-Equipment Platform (JBT FoodTech + Marel Protein/Poultry/Fish) + the Recurring Aftermarket/Service/Software Base + the New-Equipment Cycle Pipeline (~The Core Business): selected primary the combined food-processing-equipment platform (selected primary ~~~~~~~JBT FoodTech (the legacy JBT business) — food processing + packaging equipment across multiple food categories: protein (cooking, freezing/chilling, portioning, coating, frying — for meat, poultry, seafood) + liquid foods (filling, closing, sterilization/aseptic processing, pasteurization — for juices, dairy, sauces, soups, ready-to-drink) + fruit & vegetable processing + bakery + ready meals + pet food + plant-based + selected various aggregate ~~~~~~~Marel (the acquired Icelandic business) — protein-processing equipment (poultry, meat (pork, beef), fish/seafood) — primary processing (slaughter, cutting, deboning) + secondary processing (portioning, marinating, coating, cooking, freezing) + further processing (forming, breading, frying — chicken nuggets, patties, etc.) + Innova (Marel's food-production software — yield management, traceability, production-line control — a software/digital layer) + selected various aggregate ~~~~~~~the combined position — JBT + Marel together = the #1 or top-tier global player in food-processing equipment (the food-processing-equipment market is fragmented — JBT + Marel + GEA + Bühler + Krones + Middleby (food-processing segment) + many smaller players — the combination gives JBT Marel scale, breadth (across food categories, processing steps, and geographies), and a leading position in protein especially + selected various aggregate ~~~~~~~the customer base — large food/beverage manufacturers + protein processors (Tyson, JBS, Cargill, Marfrig, etc.) + dairy/beverage companies (Coca-Cola, PepsiCo, dairy co-ops) + foodservice + co-packers — globally + selected various aggregate ~~~~~~~the recurring-revenue base — ~~~~50%+ of revenue is recurring: aftermarket parts (the installed base of equipment generates ongoing demand for replacement parts — wear parts, consumables) + service (maintenance, repair, technical support, line optimization) + software (Innova + JBT's digital offerings — subscription/SaaS-like) + selected various aggregate ~~~~~~~~~~~~the recurring revenue is the quality piece — it's higher-margin, less-cyclical, sticky (the installed base of food-processing lines is huge and long-lived — equipment runs for years/decades and needs parts/service throughout), and it grows as the installed base grows; new-equipment orders are the cyclical piece + selected various aggregate ~~~~~~~the new-equipment cycle — food/beverage processors' capital spending on new lines/equipment is cyclical (tied to their volumes, capacity needs, automation investments, food-safety upgrades, new-product launches) — soft in 2023-2025 (food-manufacturer capex was cautious — inflation, demand normalization, high rates) — the recovery thesis is food-manufacturer capex picking up → new-equipment orders + revenue up + selected various aggregate ~~~~~~~the secular tailwinds — automation/labor-savings in food processing (a tight, expensive, high-turnover labor market for food-plant workers → processors automate), food safety (regulation + brand-protection → equipment upgrades), protein demand (growing global protein consumption, especially poultry → more protein-processing capacity), sustainability (energy/water efficiency, waste reduction), and yield optimization (squeezing more product out of each input — JBT Marel's software + equipment) — all driving long-run equipment + software demand) + selected various aggregate post-2024-2025 ~platform + recurring + new-equipment dynamics (selected primary ~~~~~~~recurring revenue (aftermarket parts + service + software — growing with the installed base; the quality base) + selected various aggregate ~~~~~~~new-equipment orders (the food-capex cycle — soft, recovering) + selected various aggregate ~~~~~~~the order backlog (the booked-but-not-yet-shipped new-equipment orders — a forward indicator) + selected various aggregate ~~~~~~~the segment/category mix (protein the biggest; liquid foods, fruit/veg, bakery, etc.) + selected various aggregate ~~~~~~~the geographic mix (the Americas, Europe, Asia, etc.)).
  • The JBT-Marel Integration Synergies + Deleveraging + Capital + the Secular Automation/Protein Tailwinds Pipeline (~The Value-Creation Story): selected primary the integration synergies + deleveraging + capital (selected primary ~~~~~~~the JBT-Marel merger (~2025) — JBT acquired Marel (a cash-and-stock deal — JBT shareholders + former Marel shareholders both own the combined JBT Marel) — the rationale: scale, breadth, complementary portfolios (JBT strong in liquid foods + some protein; Marel strong in protein primary/secondary/further processing), cross-selling, a stronger software/digital offering (Innova + JBT's digital), and cost synergies + selected various aggregate ~~~~~~~the cost synergies — the merger targets meaningful annual cost synergies (procurement, manufacturing footprint, SG&A, R&D efficiency, IT) — a multi-year ramp — plus revenue synergies (cross-selling, a more complete solution offering to customers) — the synergy realization is a key part of the value-creation thesis + selected various aggregate ~~~~~~~the integration risk/cost — merging two big companies (different countries — US JBT + Icelandic Marel — different cultures, ERP systems, manufacturing networks) carries integration risk + upfront integration costs (consultants, IT, restructuring) + selected various aggregate ~~~~~~~the deleveraging — the Marel acquisition added debt (JBT took on debt + issued stock to fund the cash portion + assumed Marel's debt) → JBT Marel carries a moderately-heavy debt load post-merger — ~~~3-4x net leverage initially — the free cash flow + the synergies + EBITDA growth are being used to pay it down → deleveraging is a key part of the thesis (a deleveraging-driven value transfer to equity) + selected various aggregate ~~~~~~~the capital return — modest: a small dividend (JBT has paid a dividend) + buybacks (modest — capital prioritized to deleveraging + integration + reinvestment near-term) + selected various aggregate ~~~~~~~the secular tailwinds (recap: automation/labor-savings, food safety, protein demand, sustainability, yield optimization — the long-run demand drivers for food-processing equipment + software) + selected various aggregate ~~~~~~~the recurring-revenue + software upside (as the combined installed base grows + the software offering (Innova + digital) scales, the recurring/software revenue mix rises → higher-quality, less-cyclical revenue → a multiple re-rating potential)) + selected various aggregate post-2024-2025 ~integration + deleveraging + capital + secular dynamics (selected primary ~~~~~~~the synergy realization (the cost-synergy ramp — tracking toward the target — + revenue synergies) + selected various aggregate ~~~~~~~the integration progress (ERP/systems integration, manufacturing-footprint optimization, organizational integration) + selected various aggregate ~~~~~~~deleveraging (net debt/EBITDA toward ~~~2-3x) + selected various aggregate ~~~~~~~the recurring/software revenue mix (rising — toward ~~~50%+ and higher) + selected various aggregate ~~~~~~~the new-equipment-cycle recovery (food-manufacturer capex) + selected various aggregate ~~~~~~~the dividend + modest buybacks + selected various aggregate ~~~~~~~the secular automation/protein/sustainability tailwinds).
  • Capital position + balance sheet: ~$0.40-0.44 aggregate annual dividend per share (~~~~0.3-0.6% aggregate yield; selected primary ~~~quarterly ~~~$0.10 + selected various aggregate ~~~~~~~~~~~a modest dividend — maintained through the merger) + selected various aggregate ~$0-0.3B aggregate annual buybacks (selected primary ~~~modest — capital prioritized to deleveraging + integration + reinvestment near-term; buybacks could grow as the balance sheet heals) + aggregate net debt ~$1.5-2.8B (selected various aggregate ~~~~~moderately heavy post-merger — the debt to fund the Marel acquisition + assumed Marel debt; a mix of a term loan + senior notes; the free cash flow + synergies paying it down) + selected primary ~~~~~~~~2.5-4.0x aggregate net debt / EBITDA (selected various aggregate ~~~~~elevated initially post-merger; deleveraging toward ~~~2-3x as the synergies + EBITDA growth + free cash flow work through) + BB+/Ba1 to BBB-/Baa3 aggregate credit profile (crossover — solid for an equipment company with a big recurring-revenue base) + ~~~~~70-80M aggregate diluted shares (selected various aggregate ~~~roughly stable post-merger — the merger added shares (the stock portion of the consideration); modest buybacks) + selected various aggregate ~~~free cash flow (the equipment + recurring-revenue business is decently cash-generative; the recurring revenue + the order backlog provide visibility).
  • FY2026 thesis catalysts: The Food-Processing-Equipment Platform (JBT FoodTech + Marel Protein/Poultry/Fish) + the Recurring Aftermarket/Service/Software Base + the New-Equipment Cycle pipeline (JBT FoodTech (protein cooking/freezing/portioning + liquid foods filling/sterilization + fruit/veg + bakery + ready meals + pet food) + Marel (protein primary/secondary/further processing — poultry, meat, fish — + Innova software) + the #1/top-tier global food-processing-equipment position + the ~50%+ recurring revenue base (aftermarket parts + service + software — the quality, less-cyclical piece, growing with the installed base) + the new-equipment-cycle recovery (food-manufacturer capex picking up → orders + revenue up) + the order backlog + the secular tailwinds (automation/labor-savings, food safety, protein demand, sustainability, yield optimization)) + The JBT-Marel Integration Synergies + Deleveraging + Capital + the Secular Automation/Protein Tailwinds pipeline (the JBT-Marel merger (~2025) + the cost-synergy ramp (procurement, manufacturing footprint, SG&A, R&D, IT) + revenue synergies (cross-selling) + the integration progress + deleveraging (net debt/EBITDA toward ~2-3x) + the recurring/software revenue mix rising + the dividend + modest buybacks + the secular automation/protein/sustainability tailwinds) + ~$0.40-0.44 dividend + modest buybacks + ~2.5-4.0x net debt/EBITDA + Brian Deck integration-synergy + deleveraging + recurring-revenue execution + the new-equipment-cycle recovery.

Company Background

JBT Marel Corporation (NYSE: JBTM) is a global food & beverage processing equipment and automation company, headquartered in Chicago, Illinois, formed in ~2025 when JBT Corporation acquired Marel hf. of Iceland (selected primary ~~~~JBT Corporation was spun off from FMC Technologies in 2008 (as "John Bean Technologies" — FMC FoodTech + FMC AeroTech) + selected post-2008-2023 ~~JBT as a food-tech + airport-equipment company + selected post-2023 ~~JBT spun off its AeroTech airport-ground-support-equipment business (to Oshkosh) — becoming a pure-play food-tech company + selected post-2023-2025 ~~the pursuit and completion of the Marel acquisition (a multi-year, on-and-off process — JBT bid for Marel, the Eyrir Invest / Marel shareholders negotiated, the deal closed ~2025 — creating JBT Marel, a top-tier global food-processing-equipment company) + the integration-synergy + deleveraging program + selected various aggregate ~~NYSE listing). Selected ~NYSE listing as JBT Marel (formerly JBT Corporation); selected post-2019-2025 Brian Deck CEO era (~5-7 year tenure; succeeded as JBT CEO in ~2019; prior JBT CFO/finance background; the architect of the JBT FoodTech focus (post the AeroTech spin), the Marel acquisition, the integration-synergy + deleveraging program, and the recurring-revenue + secular-automation strategy); HQ Chicago, Illinois; ~~~15,000-20,000 employees globally (post-merger).

JBTM operates as a combined food-processing-equipment company: JBT FoodTech (the legacy JBT business — food processing + packaging equipment across protein (cooking, freezing, portioning, coating, frying), liquid foods (filling, closing, sterilization/aseptic, pasteurization), fruit & vegetable processing, bakery, ready meals, pet food, plant-based) + Marel (the acquired business — protein-processing equipment for poultry, meat, fish — primary, secondary, further processing — + Innova food-production software) + recurring aftermarket/parts/service/software (~50%+ of total revenue — the quality, less-cyclical base). Together = the #1 / top-tier global player in food-processing equipment. Customers: large food/beverage manufacturers + protein processors (Tyson, JBS, Cargill, etc.) + dairy/beverage companies + foodservice + co-packers, globally. Geographic mix: the Americas ~40-45% + Europe ~30-35% + Asia/RoW ~20-25%. Capital position: ~$0.40-0.44 aggregate annual dividend per share (~0.3-0.6% yield) + ~$0-0.3B aggregate annual buybacks (modest) + aggregate net debt ~$1.5-2.8B (moderately heavy post-merger) + ~2.5-4.0x aggregate net debt/EBITDA (elevated; deleveraging) + BB+/Ba1 to BBB-/Baa3 credit profile (crossover) + ~70-80M aggregate diluted shares (roughly stable post-merger).

The Food-Processing-Equipment Platform (JBT FoodTech + Marel Protein/Poultry/Fish) + the Recurring Aftermarket/Service/Software Base + the New-Equipment Cycle Pipeline (~The Core Business)

The Food-Processing-Equipment Platform pipeline is JBTM's foundation thesis: selected primary the combined platform (selected primary ~~~~~~~JBT FoodTech (the legacy JBT business) — food processing + packaging equipment across multiple categories: protein (cooking, freezing/chilling, portioning, coating, frying — meat, poultry, seafood) + liquid foods (filling, closing, sterilization/aseptic processing, pasteurization — juices, dairy, sauces, soups, RTD) + fruit & vegetable processing + bakery + ready meals + pet food + plant-based + selected various aggregate ~~~~~~~Marel (the acquired Icelandic business) — protein-processing equipment (poultry, meat, fish/seafood) — primary processing (slaughter, cutting, deboning) + secondary processing (portioning, marinating, coating, cooking, freezing) + further processing (forming, breading, frying) + Innova (Marel's food-production software — yield management, traceability, line control) + selected various aggregate ~~~~~~~the combined position — JBT + Marel together = the #1 / top-tier global player in food-processing equipment (a fragmented market — JBT + Marel + GEA + Bühler + Krones + Middleby (food-processing segment) + many smaller players — the combination gives JBT Marel scale, breadth (categories, processing steps, geographies), and a leading position in protein especially + selected various aggregate ~~~~~~~the customer base — large food/beverage manufacturers + protein processors (Tyson, JBS, Cargill, Marfrig, etc.) + dairy/beverage companies + foodservice + co-packers — globally + selected various aggregate ~~~~~~~the recurring-revenue base — ~~~~50%+ of revenue recurring: aftermarket parts (the installed base generates ongoing replacement-part demand — wear parts, consumables) + service (maintenance, repair, technical support, line optimization) + software (Innova + JBT's digital — subscription/SaaS-like) + selected various aggregate ~~~~~~~~~~~~the recurring revenue is the quality piece — higher-margin, less-cyclical, sticky (the installed base of food-processing lines is huge and long-lived — equipment runs for years/decades and needs parts/service throughout), and it grows as the installed base grows; new-equipment orders are the cyclical piece + selected various aggregate ~~~~~~~the new-equipment cycle — food/beverage processors' capital spending on new lines/equipment is cyclical (tied to their volumes, capacity needs, automation investments, food-safety upgrades, new-product launches) — soft in 2023-2025 (cautious food-manufacturer capex — inflation, demand normalization, high rates) — the recovery thesis is food-manufacturer capex picking up → new-equipment orders + revenue up + selected various aggregate ~~~~~~~the secular tailwinds — automation/labor-savings (a tight, expensive, high-turnover food-plant labor market → processors automate), food safety (regulation + brand-protection → equipment upgrades), protein demand (growing global protein consumption, especially poultry → more capacity), sustainability (energy/water efficiency, waste reduction), yield optimization (squeezing more product out of each input — JBT Marel's software + equipment)) + selected various aggregate post-2024-2025 ~platform + recurring + new-equipment dynamics.

FY2025 The Food-Processing-Equipment Platform dynamics: selected primary ~revenue boosted by the Marel consolidation (selected primary ~~~~~~~the Marel acquisition closed ~2025 — JBT Marel's reported revenue jumps as Marel's revenue is consolidated (a step-change in scale) + selected various aggregate ~~~~~~~organically, the business was ~flat-to-modest (the soft new-equipment cycle — cautious food-manufacturer capex — partly offset by the resilient recurring revenue) + selected various aggregate ~~~~~~~recurring revenue (aftermarket parts + service + software — the quality base — held up well; ~50%+ of total) + selected various aggregate ~~~~~~~new-equipment orders soft (the cautious food-capex environment) + selected various aggregate ~~~~~~~the order backlog (a forward indicator — the booked new-equipment orders; the question is whether the backlog is growing as the cycle turns) + selected various aggregate ~~~~~~~integration costs (upfront merger-integration spending — consultants, IT, restructuring — depressing GAAP earnings)) + ~$3.5-4.5B aggregate revenue (Marel-boosted). Selected post-2024 ~$2.50-3.50 aggregate annual adj. EPS contribution (selected various aggregate ~~the combined-company earnings, before full synergy realization) as the Food-Processing-Equipment Platform pipeline drives the dominant revenue + the (pre-full-synergy) earnings.

FY2026 catalyst: continued The Food-Processing-Equipment Platform pipeline + ~$3.00-4.50 aggregate annual adj. EPS contribution (selected various aggregate ~~the synergy ramp + a new-equipment-cycle recovery lifting it) under continued Brian Deck leadership (~5-7 year tenure). Selected aggregate ~$3.6-4.7B aggregate FY2026 revenue + selected various ~~~~~~~recurring revenue (aftermarket parts + service + software — growing with the installed base + the combined-company scale + the Innova/digital push — the quality base; the mix rising toward ~50%+ and higher) + selected various aggregate ~~~~~~~new-equipment orders (the food-capex cycle — recovering as food-manufacturer capex picks up; the order backlog growing) + selected various aggregate ~~~~~~~the category/geographic mix (protein the biggest — riding the protein-demand tailwind; liquid foods, fruit/veg, bakery; the Americas, Europe, Asia) + selected various aggregate ~~~~~~~the secular tailwinds driving demand (automation/labor-savings, food safety, protein demand, sustainability, yield optimization) + selected various aggregate ~~~~~~~the cross-selling (the combined portfolio — selling JBT + Marel solutions together to customers — revenue synergies). Risks: in food-processing equipment — GEA Group (Germany; GEA — a major food-processing-equipment competitor — dairy, beverage, food, pharma) + Bühler (Switzerland; private — grain/food processing — a big private competitor) + Krones (Germany; KRN — beverage/packaging equipment) + Middleby (MIDD — its Food Processing segment, which Middleby is spinning off) + Tetra Pak / Tetra Laval (private — liquid-food processing + packaging — a giant private competitor in liquid foods) + SPX FLOW (private — food/beverage processing) + Marel's-former-protein-competitors (Baader (private — fish processing), Provisur, etc.) + Duravant (private), and many smaller niche players + selected various aggregate food-processing-equipment competitive considerations + the food-manufacturer-capex-cycle considerations (the central near-term risk — new-equipment orders track food/beverage processors' capital spending, which is cyclical — soft in 2023-2025; a recession or continued cautious capex would extend the soft new-equipment cycle (though the recurring revenue is a buffer)) + the integration-execution considerations (the central merger risk — combining two big companies — US JBT + Icelandic Marel — different countries, cultures, ERP systems, manufacturing networks — carries integration risk; a botched integration (synergies missed, customer disruption, employee attrition, ERP problems) would hurt; the integration is a multi-year process) + the synergy-realization considerations (the cost-synergy target — the deal's value depends on hitting it; revenue synergies (cross-selling) are harder to bank) + the protein-demand / agriculture-cycle considerations (protein processing — the biggest category — is tied to global protein consumption + the protein processors' health (commodity prices — feed, livestock — affect their margins + capex) + animal-disease outbreaks (avian flu, ASF — can disrupt poultry/pork processing) + the plant-based-meat trajectory (a slowdown there is neutral-to-positive for animal-protein equipment)) + the customer-concentration considerations (large protein/food processors — Tyson, JBS, Cargill, etc. — exert pricing pressure; a major customer cutting capex hurts) + the recurring-revenue considerations (the recurring base is the quality piece — but it depends on the installed base running (a plant-closure wave would reduce it) + processors choosing JBT Marel parts/service over third-party/refurbished alternatives) + the geographic / FX considerations (~half the revenue outside the US — Europe, Asia — FX + regional-economic exposure) + the deleveraging considerations (loops back — the merger added debt; deleveraging depends on free cash flow + synergies + EBITDA growth — a soft cycle slows it).

The JBT-Marel Integration Synergies + Deleveraging + Capital + the Secular Automation/Protein Tailwinds Pipeline (~The Value-Creation Story)

The JBT-Marel Integration Synergies + Deleveraging + Capital pipeline is JBTM's value-creation thesis: selected primary the integration synergies + deleveraging + capital (selected primary ~~~~~~~the JBT-Marel merger (~2025) — JBT acquired Marel (a cash-and-stock deal — JBT shareholders + former Marel shareholders both own the combined JBT Marel) — the rationale: scale, breadth, complementary portfolios (JBT strong in liquid foods + some protein; Marel strong in protein primary/secondary/further processing), cross-selling, a stronger software/digital offering (Innova + JBT's digital), and cost synergies + selected various aggregate ~~~~~~~the cost synergies — the merger targets meaningful annual cost synergies (procurement — combined purchasing power — manufacturing footprint — consolidating/optimizing plants — SG&A — eliminating duplicate corporate/back-office — R&D efficiency — combining engineering — IT — one ERP/systems) — a multi-year ramp — plus revenue synergies (cross-selling — selling JBT + Marel solutions together; a more complete solution offering) — the synergy realization is a key part of the value-creation thesis + selected various aggregate ~~~~~~~the integration risk/cost — merging two big companies (different countries, cultures, ERP systems, manufacturing networks) carries integration risk + upfront integration costs (consultants, IT, restructuring — a multi-year spend that depresses near-term GAAP earnings) + selected various aggregate ~~~~~~~the deleveraging — the Marel acquisition added debt (JBT took on debt + issued stock to fund the cash portion + assumed Marel's debt) → JBT Marel carries a moderately-heavy debt load post-merger — ~~~3-4x net leverage initially — the free cash flow + the synergies + EBITDA growth are being used to pay it down → deleveraging is a key part of the thesis (a deleveraging-driven value transfer to equity — every turn of deleveraging shifts value from debt to equity) + selected various aggregate ~~~~~~~the capital return — modest: a small dividend (JBT has paid a dividend) + buybacks (modest — capital prioritized to deleveraging + integration + reinvestment near-term) + selected various aggregate ~~~~~~~the secular tailwinds (recap: automation/labor-savings, food safety, protein demand, sustainability, yield optimization — the long-run demand drivers for food-processing equipment + software) + selected various aggregate ~~~~~~~the recurring-revenue + software upside (as the combined installed base grows + the software offering (Innova + digital) scales, the recurring/software revenue mix rises → higher-quality, less-cyclical revenue → a multiple re-rating potential — the market values high-recurring-revenue equipment companies (like Roper, etc.) more richly than pure-cyclical-equipment companies)) + selected various aggregate post-2024-2025 ~integration + deleveraging + capital + secular dynamics.

FY2025 The JBT-Marel Integration Synergies + Deleveraging + Capital dynamics: selected primary ~the post-merger integration year (selected primary ~~~~~~~the Marel acquisition closed 2025 — the integration begins: standing up the combined organization, starting the synergy programs (procurement, footprint, SG&A, IT), upfront integration costs + selected various aggregate ~~~~~~~early cost synergies (the first tranche of the cost-synergy ramp — procurement + SG&A typically come first) + selected various aggregate ~~~~~~~the leverage elevated (3-4x net debt/EBITDA — the deal added debt + Marel's debt; the soft-EBITDA year (the soft new-equipment cycle) makes the ratio look worse) + selected various aggregate ~~~~~~~the free cash flow (decently cash-generative — the recurring revenue + the order backlog provide visibility — going to debt paydown + integration) + selected various aggregate ~~~~~~~the capital return — the dividend ($0.40-0.44 annual — maintained) + modest buybacks ($0-0.3B FY2025 — limited near-term, with deleveraging the priority)). Selected post-2024 ~$0.50-1.00 aggregate annual adj. EPS contribution (selected various aggregate ~~mostly the synergy-driven margin improvement + the deleveraging-driven interest-expense reduction — these build over time) as the JBT-Marel Integration Synergies + Deleveraging + Capital pipeline drives the value-creation lever.

FY2026 catalyst: continued The JBT-Marel Integration Synergies + Deleveraging + Capital pipeline + $0.50-1.00 aggregate annual adj. EPS contribution + selected various aggregate ~~~~~~~the synergy realization (the cost-synergy ramp continuing — tracking toward the multi-year target — procurement, manufacturing-footprint optimization, SG&A, R&D, IT; revenue synergies from cross-selling starting) + selected various aggregate ~~~~~~~the integration progress (ERP/systems integration, manufacturing-footprint consolidation, organizational integration — milestones) + selected various aggregate ~~~~~~~deleveraging (net debt/EBITDA toward ~~~2-3x — the free cash flow + synergies + EBITDA growth + lower interest expense flowing to EPS) + selected various aggregate ~~~~~~~the recurring/software revenue mix (rising — toward ~~~50%+ and higher — the quality piece growing; the Innova/digital push) + selected various aggregate ~~~~~~~the new-equipment-cycle recovery (food-manufacturer capex picking up — new-equipment orders + revenue + the backlog) + selected various aggregate ~~~~~~~the dividend ($0.40-0.44 — maintained/grown) + modest buybacks (growing as the balance sheet heals) + selected various aggregate ~~~~~~~the secular automation/protein/sustainability tailwinds (the long-run demand drivers — continuing). Risks: in the integration + value-creation — GEA Group (GEA), Bühler (private), Krones (KRN), Middleby (MIDD — its Food Processing segment spin), Tetra Pak (private), Marel's-former-protein-competitors (Baader — private, Provisur, etc.), Duravant (private) — food-processing-equipment competitors (a competitor could exploit JBT Marel's integration distraction to take share) + on the recurring-revenue/software model — the high-recurring-revenue equipment comps (Roper, etc. — for the valuation lens) + selected various aggregate food-processing-equipment + value-creation considerations + the integration-execution considerations (the central risk — the value of the merger depends on a successful integration; integration distractions, customer disruption, employee attrition, ERP problems, or a slower-than-expected synergy ramp would hurt; the multi-year integration is a key thing to track) + the synergy-realization considerations (the cost-synergy target — hit it and the deal creates value; miss it and the deal underdelivers; revenue synergies are harder to bank) + the deleveraging-pace considerations (deleveraging depends on free cash flow + synergies + EBITDA growth — a soft new-equipment cycle slows it; a recession would slow it materially) + the food-capex-cycle considerations (loops back — the new-equipment cycle is the swing for the revenue + EBITDA + thus the deleveraging) + the management-execution considerations (Brian Deck + the combined-company leadership — running a much bigger, more complex company through a major integration) + the recurring-revenue-mix considerations (the bull case includes a recurring/software-mix-driven multiple re-rating — but that requires the recurring/software revenue to keep growing as a share + the market to credit it) + the capital-allocation considerations (deleveraging vs the dividend vs buybacks vs reinvestment — JBT Marel has leaned toward deleveraging + integration near-term) + the regulatory considerations (the merger had to clear antitrust in multiple jurisdictions — it did, possibly with some divestiture conditions; future M&A could face scrutiny given the now-larger position).

Capital Position + Balance Sheet

Capital position + balance sheet: ~$0.40-0.44 aggregate annual dividend per share (~~~~0.3-0.6% aggregate yield; selected primary ~~~quarterly ~~~$0.10 + selected various aggregate ~~~~~~~~~~~a modest dividend — maintained through the merger; JBT has paid a small dividend for years) + selected various aggregate ~$0-0.3B aggregate annual buybacks (selected primary ~~~modest — capital prioritized to deleveraging + integration + reinvestment near-term; buybacks could grow as the balance sheet heals + the integration completes) + aggregate net debt ~$1.5-2.8B (selected various aggregate ~~~~~moderately heavy post-merger — the debt JBT took on to fund the cash portion of the Marel deal + assumed Marel debt; a mix of a term loan + senior notes; the free cash flow + synergies + EBITDA growth paying it down) + selected primary ~~~~~~~~2.5-4.0x aggregate net debt / EBITDA (selected various aggregate ~~~~~elevated initially post-merger — and the soft-EBITDA year (the soft new-equipment cycle) makes the ratio look worse; deleveraging toward ~~~2-3x as the synergies + EBITDA growth + free cash flow work through — the central financial-thesis metric) + BB+/Ba1 to BBB-/Baa3 aggregate credit profile (crossover — solid for an equipment company with a ~50%+ recurring-revenue base, which is more stable than a pure-cyclical-equipment company; deleveraging should support an IG profile over time) + ~~~~~70-80M aggregate diluted shares (selected various aggregate ~~~roughly stable post-merger — the merger added shares (the stock portion of the consideration paid to former Marel shareholders); modest buybacks) + weighted average debt maturity ~3-6 years + selected various aggregate ~~~~~$0.4-0.8B aggregate liquidity (cash + an undrawn revolver) + selected various aggregate ~~~free cash flow (the equipment + recurring-revenue business is decently cash-generative; the recurring revenue + the order backlog provide visibility; FCF should grow as the synergies ramp + the new-equipment cycle recovers).

FY2026 catalyst: continued dividend (~$0.40-0.44 aggregate annual; selected various aggregate ~~~maintained/modestly grown) + selected continued ~$0-0.3B aggregate annual buybacks (selected primary ~~~modest near-term — deleveraging + integration the priority; buybacks could grow as the balance sheet heals) + selected various aggregate ~~~~~2.5-4.0x → ~2-3x aggregate net debt/EBITDA (selected primary ~~~deleveraging on the free cash flow + the synergy-driven EBITDA growth + the new-equipment-cycle recovery + lower interest expense flowing to EPS) + selected various aggregate ~~~~debt paydown + refinancing/maturity management + selected various aggregate ~~~~the integration-cost rolloff (the upfront integration spending tapering as the integration progresses — improving GAAP earnings) + selected continued BB+/Ba1 to BBB-/Baa3 credit profile (improving on deleveraging — toward an IG profile over time). Selected the dividend + selected modest buybacks + selected ~the deleveraging + selected ~the recurring-revenue-backed free cash flow support the combined-food-tech-equipment-leader-with-a-big-recurring-aftermarket-and-merger-synergies model — the combined food-processing-equipment platform (the #1/top-tier global position, the protein strength, the breadth) + the ~50%+ recurring revenue (the quality, less-cyclical base) + the JBT-Marel merger synergies (cost + revenue) + the deleveraging + the secular automation/protein/sustainability tailwinds combining for a synergy-realization + new-equipment-cycle-recovery + deleveraging + recurring-revenue-re-rating thesis, gated by the integration execution and the food-capex cycle.

Key Core Metrics

  • FY2025 revenue ~$3.5-4.5B (boosted by the Marel consolidation, then ~flat-to-modest organically) vs JBT's pre-merger ~$1.7-1.8B (JBT standalone); adj. EPS ~$3.50-5.50 (highly merger-integration- + food-capex-cycle-sensitive; GAAP lumpy on acquisition/integration charges + amortization; the thesis is synergy realization + a new-equipment-cycle recovery + deleveraging)
  • The combined company: JBT FoodTech (the legacy JBT business — food processing + packaging equipment across protein (cooking, freezing, portioning, coating, frying), liquid foods (filling, closing, sterilization/aseptic, pasteurization), fruit & vegetable processing, bakery, ready meals, pet food, plant-based) + Marel (the acquired Icelandic business — protein-processing equipment for poultry, meat, fish — primary, secondary, further processing — + Innova food-production software) = the #1 / top-tier global player in food-processing equipment
  • The recurring-revenue base: ~50%+ of revenue is recurring — aftermarket parts (the installed base generates ongoing replacement-part demand) + service (maintenance, repair, technical support, line optimization) + software (Innova + JBT's digital — subscription/SaaS-like) — the quality piece (higher-margin, less-cyclical, sticky; grows with the installed base)
  • The new-equipment cycle: food/beverage processors' capital spending on new lines/equipment is cyclical (tied to their volumes, capacity needs, automation investments, food-safety upgrades, new-product launches) — soft in 2023-2025 (cautious food-manufacturer capex — inflation, demand normalization, high rates) — the recovery thesis is food-manufacturer capex picking up → new-equipment orders + revenue + the backlog up
  • The secular tailwinds: automation/labor-savings (a tight, expensive, high-turnover food-plant labor market → processors automate) + food safety (regulation + brand-protection → equipment upgrades) + protein demand (growing global protein consumption, especially poultry → more capacity) + sustainability (energy/water efficiency, waste reduction) + yield optimization (squeezing more product out of each input — JBT Marel's software + equipment)
  • The JBT-Marel merger (~2025): a cash-and-stock deal (JBT shareholders + former Marel shareholders both own the combined JBT Marel) — the rationale: scale, breadth, complementary portfolios (JBT strong in liquid foods; Marel strong in protein), cross-selling, a stronger software/digital offering, and cost synergies; meaningful annual cost-synergy targets (procurement, manufacturing footprint, SG&A, R&D, IT) — a multi-year ramp — plus revenue synergies (cross-selling)
  • The order backlog: the booked-but-not-yet-shipped new-equipment orders — a forward indicator
  • Customers: large food/beverage manufacturers + protein processors (Tyson, JBS, Cargill, Marfrig, etc.) + dairy/beverage companies (Coca-Cola, PepsiCo, dairy co-ops) + foodservice + co-packers — globally
  • Aggregate adj. EBITDA margin: ~14-18%+ (recovering — the recurring revenue is higher-margin; the synergies + a new-equipment-cycle recovery + cost cuts lift it over time)
  • Aggregate net debt: ~$1.5-2.8B (moderately heavy post-merger — the debt to fund the Marel deal + assumed Marel debt); ~2.5-4.0x aggregate net debt/EBITDA (elevated initially; deleveraging toward ~2-3x — the central financial-thesis metric)
  • BB+/Ba1 to BBB-/Baa3 aggregate credit profile (crossover — solid for an equipment company with a ~50%+ recurring-revenue base; deleveraging should support an IG profile over time)
  • ~70-80M aggregate diluted shares (roughly stable post-merger — the merger added shares (the stock portion); modest buybacks); ~$0.03B total dividends FY2025
  • Dividend: ~$0.40-0.44 aggregate annual per share (~0.3-0.6% yield; quarterly ~$0.10; a modest dividend — maintained through the merger)
  • Modest buybacks (~$0-0.3B aggregate annual — capital prioritized to deleveraging + integration + reinvestment near-term; could grow as the balance sheet heals)
  • ~$0.4-0.8B aggregate liquidity (cash + an undrawn revolver)
  • Free cash flow: the equipment + recurring-revenue business is decently cash-generative; the recurring revenue + the order backlog provide visibility; FCF should grow as the synergies ramp + the new-equipment cycle recovers
  • Geographic mix: the Americas ~40-45% + Europe ~30-35% + Asia/RoW ~20-25%
  • ~15,000-20,000 employees globally (post-merger)
  • Brian Deck President + CEO since ~2019 (~5-7 year tenure as JBT/JBT Marel CEO; prior JBT CFO/finance background; the architect of the JBT FoodTech focus (post the AeroTech spin), the Marel acquisition, and the integration-synergy + deleveraging program)
  • HQ Chicago, Illinois; JBT spun off from FMC Technologies 2008; spun off AeroTech (to Oshkosh) ~2023; acquired Marel hf. of Iceland ~2025 (creating JBT Marel); NYSE listing

Market Evaluation

JBTM FY2026 market evaluation: at ~$80-140 share price + ~70-80M aggregate diluted shares = ~$6-11B equity market cap; ~$8-14B aggregate enterprise value (incl. ~$1.5-2.8B net debt); ~$0.40-0.44 aggregate annual dividend (~0.3-0.6% aggregate yield). Selected primary JBTM peers: GEA Group (Germany; GEA — a major food-processing-equipment competitor — the closest large public comp) + Krones (Germany; KRN — beverage/packaging equipment) + Middleby (MIDD — its Food Processing segment (being spun off) — a direct food-processing-equipment comp) + Tetra Pak / Tetra Laval (private — liquid-food processing + packaging) + Bühler (Switzerland; private — grain/food processing) + on the high-recurring-revenue / process-equipment-compounder lens — Roper Technologies (ROP — for the recurring-revenue-re-rating comp), Dover (DOV), Ingersoll Rand (IR), Watts Water (WTS), Mueller Industries, Graco (GGG), Nordson (NDSN), Lincoln Electric (LECO) + on the broad industrial-equipment lens — Illinois Tool Works (ITW), Parker Hannifin (PH), Emerson (EMR) + selected various aggregate food-processing-equipment + process-equipment + industrial companies. Selected JBTM ~15-25x P/E (a combined food-processing-equipment leader — JBT FoodTech + Marel — the #1/top-tier global position, the protein strength, the breadth, a ~50%+ recurring-revenue base (aftermarket parts + service + software — the quality, less-cyclical piece), the JBT-Marel merger synergies (cost + revenue), the secular automation/protein/sustainability tailwinds, and a deleveraging post-merger balance sheet — with the near-term swing being the integration execution + the food-capex cycle; the P/E reflects the recurring-revenue quality (a premium to pure-cyclical-equipment) but is tempered by the integration risk + the leverage + the soft cycle) + selected ~~~9-14x EV/EBITDA + selected ~~~~2-3x EV/Sales + ~0.3-0.6% dividend yield + selected aggregate ~$3.6-4.7B aggregate FY2026 revenue + selected aggregate ~$3.50-5.50 aggregate FY2026 adj. EPS + selected aggregate The Food-Processing-Equipment Platform + The JBT-Marel Integration Synergies + Deleveraging pipeline. FY2026 base case: ~$3.6-4.7B aggregate revenue + ~$3.50-5.50 adj. EPS + ~14-18%+ adj. EBITDA margin (rising on synergies) + ~2.5-4.0x → ~2-3x net debt/EBITDA (deleveraging) + the dividend + modest buybacks + the synergy ramp on track. Bull case: The Food-Processing-Equipment Platform pipeline acceleration (a new-equipment-cycle recovery — food-manufacturer capex picking up → new-equipment orders + revenue + the backlog up + the recurring revenue + the secular automation/protein/sustainability tailwinds + cross-selling) + The JBT-Marel Integration Synergies + Deleveraging pipeline acceleration (the cost synergies fully realized (hitting/exceeding the target) + revenue synergies materializing + the integration completed smoothly + deleveraging toward ~2x (an IG-profile re-rating) + the recurring/software revenue mix rising (a recurring-revenue-driven multiple re-rating — the market values JBT Marel more like a Roper-style process-equipment compounder)) + the dividend + growing buybacks drives ~$3.9-5.0B aggregate revenue + ~$5.00-7.00 adj. EPS + a multiple re-rating. Bear case: GEA + Krones + Middleby + Tetra Pak + Bühler competitive considerations (a competitor exploiting JBT Marel's integration distraction to take share) + a prolonged soft new-equipment cycle (a recession or continued cautious food-manufacturer capex — new-equipment orders + revenue stay depressed; the recurring revenue is a buffer but not enough) + integration-execution missteps (synergies missed, customer disruption, employee attrition, ERP problems — the merger underdelivers) + the deleveraging stalling (a soft cycle + missed synergies → the leverage stays elevated) + a protein-demand/agriculture-cycle shock (commodity-price pressure on processors, animal-disease outbreaks — avian flu, ASF) + customer-concentration pressure (the large processors cutting capex) + a credit-rating concern (the leverage in a soft cycle) + the integration-cost drag persisting + the high-P/E-without-the-recurring-re-rating de-rating drives ~$3.4-3.8B revenue + ~$2.80-3.80 adj. EPS + a de-rating. The thesis depends on The Food-Processing-Equipment Platform (JBT FoodTech + Marel Protein/Poultry/Fish) + the Recurring Aftermarket/Service/Software Base + the New-Equipment Cycle pipeline + The JBT-Marel Integration Synergies + Deleveraging + Capital + the Secular Automation/Protein Tailwinds pipeline + the #1/top-tier global food-processing-equipment position + the protein strength + the ~50%+ recurring revenue (the quality, less-cyclical base) + the JBT-Marel merger synergies (cost + revenue) + the integration execution + the deleveraging (net debt/EBITDA toward ~2-3x) + the new-equipment-cycle recovery + the secular automation/protein/sustainability tailwinds + the recurring/software revenue mix rising + the dividend + modest buybacks + Brian Deck integration-synergy + deleveraging + recurring-revenue execution.